David Hopkinson obituary
My friend and former colleague David Hopkinson, who has died aged 89, was director of the Medical Research Council's human biochemical genetics unit at University College London from 1976 until its closure in 2000.
Hoppy, as he was universally known, had joined the unit at its inception in 1962 because in an earlier, more junior, position he had been one of the first medical scientists to describe molecular differences in human enzymes, long before DNA sequence differences were known about.
The unit was established to research the extent and significance of genetic variation to human health. As its head, Hoppy expanded its focus to gene mapping and disease genetics while also moving into the new science of gene cloning and DNA sequencing.
Born in Chesterfield, Derbyshire, to Albert Hopkinson, an iron and steelworks foreman, and Lilian (nee Siddal), a dressmaker, he went to Chesterfield grammar school, which fostered his early interest in organic chemistry. After completing a natural sciences degree at Cambridge University he qualified in medicine at the London hospital in 1959, working there until he joined the human biochemical genetics unit three years later.
Hoppy was recruited by its inaugural head, Prof Harry Harris, becoming his right-hand man responsible for many of the unit's innovative experimental approaches, including developing novel methods of enzyme detection and electrophoresis.
The unit moved in 1965 from its initial base at King's College to UCL, where I joined the unit three years later to study for a PhD under Harris. Hoppy remained there for the rest of his career. He published widely, and played an important part in teaching and supervision, being made full professor of London University in 1990. Twenty five years after his retirement, his role as mentor is remembered with great warmth by his former staff and students.
Hoppy read widely and appreciated drama and music. A practical man who took pleasure in manual labour, he was an accomplished gardener and delighted in propagating plants and growing vegetables. He also enjoyed summers hiking in the Swiss Alps, and was a keen birdwatcher.
In retirement, he studied architecture and German, and gained a first-class degree in geology at the Open University. He also spent many years as a volunteer at Chilterns' Citizens Advice in Chesham, Buckinghamshire.
He is survived by his second wife, Prof Yvonne Edwards, and by three children, Paul, Susan and Ian, from his first marriage, to Josephine (nee Manze), which ended in divorce, and four grandchildren.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
13 hours ago
- Wall Street Journal
Three Siblings, One Fatal Gene: A Family's Fight Against Early-Onset Alzheimer's
Hannah Richardson is hopeful about her future and its endless possibilities. But the 24-year-old's plans are clouded by an unthinkable reality—there is a 50% chance she will develop Alzheimer's disease in her 30s. Hannah's family has a history of a rare genetic mutation that, when inherited, virtually guarantees that the carrier will die of an aggressive form of Alzheimer's early in life. No drug has been found to stop it. But now researchers are exploring a new avenue: Could pre-emptive treatment slow or even halt the memory-robbing disease in people at high risk of developing it?
Yahoo
17 hours ago
- Yahoo
I found a bacteria-eating virus in my loo - could it save your life?
I'm on the hunt for a microbial saviour – a type of virus that can treat infections rather than cause them. We all know the viral bad guys – Covid, flu, norovirus, herpes, chicken pox, measles… the list goes on. But there's a type of virus that's not interested in infiltrating our bodies, instead it preys on bacteria. They're known as bacteria eaters, or bacteriophage, or commonly as phage. Capturing them could give us new ways of treating infections, including superbugs that are becoming incurable. So, how to catch a killer? I've been promised it's surprisingly easy. The team at the Phage Collection Project sent me some vials to collect samples, along with a pair of gloves. All I need to do is hunt for some dirty water, the dirtier the better, dip the vials in and screw on the lid. I tried a couple of ponds, the juice from a worm-composting bin and then I needed my dirtiest sample. I didn't flush the toilet after a poo and left it for a couple of hours. I pop on a glove and hold my breath as I go in for the final sample. Strict hygiene instructions, including vigorous hand-washing, were followed, at all times. The vials were packaged up for collection and then three days later I headed off to the University of Southampton to see what was inside. "They were a bit dirty when I received them," phage scientist Michelle Lin tells me as we don our blue lab-coats and matching gloves to go into the Containment Level 2 microbiology laboratory. We grab my samples from the fridge, which look much clearer now they have been filtered of any… debris. "It's fine, it's needed," Michelle, who had the unpleasant job, reassures me. Filtering is the first step in looking for phage, next they get served dinner – a cocktail of yummy bacteria - to help them grow in number. Now comes the really cool bit – finding a useful phage. The scientists have been working with the local hospital to collect bacteria from patients with troublesome infections. Michelle grabs a petri dish that's growing bacteria from a patient with a painful, urinary tract infection that keeps coming back. And to my amazement – one of the phage I collected from my toilet was able to kill this infection in the lab. "The way to see that the phage has infected bacteria is you get these zones where the bacteria are not growing and that's because they've been killed by the phage," says Michelle. You can see the leopard print pattern in the petri dish where the phage have been making light work of a bacterial infection that modern medicine was struggling to shift. "As crazy as it sounds, well done to the toilet sample," says Michelle with great delight. And when I was offered the chance to name the phage, well of course it's the Gallagher-phage. "Sounds amazing to me," says Michelle. So far this is all good fun in the laboratory, but could my phage ever be given to a patient? "Yes and I hope so," says associate professor Dr Franklin Nobrega as we look at images of my phage captured with an electron microscope. "Your phage, already in just 24 hours, we were able to get in a high concentration and able to be a very good killer, which means this is very promising for patients, so thank you," said Dr Nobrega. Phage remind me of a moon lander – a big capsule on spindly legs – just instead of landing on the surface of the moon they use their legs to select their victim. They then hijack the bacteria and transform it into a mass-production factory for more phage, which burst out of their host, killing it in the process. There are pros and cons to phage. They reproduce as they go along so you don't need constant doses like you would with drugs. They are also very picky eaters. You need a precise match between phage and the strain of bacteria you're trying to treat whereas antibiotics tend to kill everything good and bad. So it is harder to find the right phage, but if you do it comes with fewer side effects. Dr Nobrega tells me infected wounds are a "very good application" for phage because you can apply them directly to the injury, but they can also be inhaled via a nebuliser to treat lung infections or to target urinary tract infections "which is our target currently". Phage science may sound new and exciting, but it is actually a century old idea stemming from the discoveries of Felix d'Hérelle and Frederick Twort in the 1910s. Bacteriophage therapy was a branch of medicine and the idea was compelling. Even as late as the 1940s there was an active pharmaceutical industry in western countries trying to produce phage-therapy to defeat bacterial infections. However, it was rapidly eclipsed by the wonder-drug of the 20th century. "Antibiotics were working so well that most people said 'why bother'," says Dr Nobrega. Work on phage therapy continued in places like Georgia and there are individual accounts of it working wonders; but there hasn't been the same depth of medical research and clinical trials as there have for drugs. But just as the initial success of antibiotics suppressed phage research, the failure of antibiotics is reigniting excitement at their potential. More than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's known as the "silent pandemic". By 2050, that figure is projected to reach 10 million a year. This "antibiotic apocalypse" would mean common infections could kill again and undermine modern medicine. The drugs are also used to make organ transplants, open surgery and chemotherapy possible. "The predictions around antibiotic resistance are very frightening, but the reality is we're seeing it now and it's only going to get worse," says Prof Paul Elkington, the director of the institute for medical innovation at the University of Southampton. He is also a doctor with a speciality in lung medicine and is already at the point where - after a year of treatment and turning to ever more toxic and less effective antibiotics - "in the end you have to have a conversation [and say] 'we can't treat this infection, we're really sorry'". He says we can't rely solely on antibiotics in the future and phage are a potential alternative. But he warns the steps needed to get from the laboratory and into patients are "uncharted". Things are changing. Phage therapy is available in the UK on compassionate grounds when other treatments have failed. And the drugs regulator – The Medicines and Healthcare products Regulatory Agency – has published its first official rules to support the development of phage therapy. "If one looks 15-20 years into the future, with the emerging methodologies, it's going to be possible for them to be much more widely available and for doctors to prescribe phage instead of antibiotics for some infections," says Prof Elkington. If you want to see if you can find a friendly virus too then The Phage Collection Project are launching their new sampling kits at the Summer Science Exhibition taking place this week at the Royal Society and through their website. "Antimicrobial resistance is something that could affect all of us," says Esme Brinsden from the Phage Collection Project, "when the public get involved they may just find the next phage that can help treat and save a patient's life". Photography by the BBC's Emma Lynch
Yahoo
a day ago
- Yahoo
Locals alarmed as 'swarms of alien jellyfish' wash up on popular beaches: 'They can find themselves stranded on the shore'
The beaches around a popular English seaside destination are being overrun with vast numbers of moon jellyfish. Though generally harmless to humans, the sight is a warning sign of a more serious problem. The Mirror reports that "swarms of alien jellyfish" are washing up on the beaches around Torquay in southwest England. Despite their otherworldly appearance, moon jellyfish are actually native to the coastal waters of the U.K. and are common throughout the world. They are almost entirely water and lack both a brain and a heart. Unlike their venomous cousins, moon jellyfish pose no threat to people. They are weak swimmers, and as Alexandra Bulgakova of the Marine Conservation Society explained to The Mirror: "Warm waters and abundant food can lead to jellyfish blooms, and if combined with onshore winds, they can find themselves stranded on the shore." Moon jellyfish are plentiful and occupy a low position in the food chain. They serve as an essential food source for many marine species, including sea birds, fish, sharks, and turtles. According to the National Marine Sanctuary Foundation, moon jellyfish are an indicator species. When their numbers explode, it's a sign that the health of the ocean's ecosystem is declining, as there are fewer predators to keep their numbers under control. In the historically temperate U.K., soaring ocean temperatures and vast blooms of jellyfish are a sure sign that something's amiss. In general, warmer waters are conducive to extreme weather events, and British authorities issued heatwave and storm warnings in June 2025, per the BBC. Keeping moon jellyfish under control and, by extension, improving the overall health of the ocean begins with raising awareness of key environmental issues. Another practical and key step to ensuring less plastic ends up in the ocean is by reducing plastic waste. It's also essential to support local initiatives and back political candidates who prioritize the environment. Do you think your city does a good job of managing trash and waste? Yes Usually Only sometimes Not at all Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.
